To be considered a specialist in prostate cancer, the treating specialist must possess comprehensive knowledge that extends beyond simply knowing current treatment modalities. They must have a deep understanding of historical landmark…
Read more
Locally advanced prostate cancer (LAPC) refers to tumors that have grown outside the prostate capsule or spread to immediately adjacent tissues (like the seminal vesicles or pelvic wall) but has not yet metastasised to distant organs. Management…
Read more
An Evidence Based Approach In Prostate Cancer Treatment As medical professionals, our patient management should be evidence-based, not on hearsay or public social media discourse. Evidence-based medicine is the conscientious, explicit, and judicious use of…
Read more
I have been quiet as a columnist for several months, swept away by the demands of practice and research. But last weekend, my mentor who keeps me updated with the latest science…
Read more
Beyond Radical Prostatectomy (RP) and Radiotherapy (RT), several focal therapy modalities have emerged. As of 2026, Focal Therapy in localised prostate cancer is considered a non-standard investigational option for clinically localised low and intermediate risk prostate cancer patients who wish to avoid…
Read more
Radiotherapy is a standard, highly effective treatment for prostate cancer, often offering cure rates comparable to surgery. It is used as a primary treatment for localised disease, combined with hormone…
Read more
External beam radiotherapy, along with radical prostatectomy (surgery), has been a mainstay treatment option for localised prostate cancer and is currently recommended by numerous guidelines for the treatment of intermediate- and high-risk localised disease. Radiation therapy (radiotherapy) is one…
Read more
Localised prostate cancer refers to cancer strictly contained within the prostate gland, having not spread to the capsule, surrounding tissues, or distant parts of the body. It is often described as…
Read more
Localised prostate cancer is cancer that has not spread outside the prostate gland, often referred to as organ-confined (stage T1/T2). It is often slow-growing, has a high likelihood of recovery, and…
Read more
Prostate cancer is the common non-cutaneous cancer and the second commonest cause of cancer death in U.S. and is at present at an increasing trend in Malaysia and the Southeast…
Read more